Status
Conditions
Treatments
About
Study Hypothesis: This study is designed as an integral part of the development of new or improved features or components of the Bravo® pH Monitoring System and may serve verification and validation purposes.
The study population will include symptomatic patients with known or suspected gastroesophageal reflux disease
Symptomatic patients will undergo invasive procedure, including Bravo capsule delivery, positioning and attachment. Confirmation of capsule attachment may be done endoscopically.
These procedures will serve to evaluate overall system performance in actual clinical setup, for instance: ergonomics and performance of delivery device, capsule transmission etc.
Physician may be asked to provide feedback on the procedure and/or document their activities during the procedure.
Full description
The study population consists of symptomatic patients with known or suspected gastro esophageal reflux disease. The aim of this clinical study is to evaluate Bravo® pH Monitoring System.
Primary objectives
To evaluate usability and functionality of the Bravo® pH Monitoring System and procedure
To evaluate modifications to the Bravo delivery device Primary Endpoints
Evaluate physician subjective assessment questionnaire (appendix 3) Percentage of successful capsule attachments Patients will undergo standard-of-care Bravo pH procedure. Prior to the pH study, the patient should not eat or drink for a minimum of 6 hours, according to the standard system instructions. Bravo procedure may take 48-96 hours Patients will have a follow-up visit or call, one to two weeks after the procedure A fluoroscopy procedure may be ordered at physician's discretion to verify capsule attachment \ detachment from the patient's esophagus
Over all expected duration for subject's participation in the study will be a maximum of 1 month
Physician may be asked to provide feedback on the procedure usability and functionality and to document their activities during the procedure.
Sex
Ages
Volunteers
Inclusion criteria
Subject age ≥ 18 years old
Subject received an explanation about the nature of the study and agrees to provide written informed consent.
The subject was referred for pH monitoring procedure to detect acid reflux for at least one of the following reasons:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
0 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal